Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation

References

• Herfindal ET, Gourley DR, Hart LL. Clinical pharmacy and therapeutics. In: Stimmel GL, editor. Schizophrenia. Baltimore, MD: Williams and Wilkins, 1992:944–956.
   Google Scholar
• Davis JM, Janicak PG, Singla A, Sharma RP. Antipsychotic drugs and their side effects. In: Barnes T, editor. Maintenance medication. London: Academic Press, 1993:183–203.
   Google Scholar
• Ramstack M, Grandolfi G, Mannaert E, D’Hoore P, Lasser R. Long-acting risperidone: Prolonged-release injectable delivery of risperidone using medisorbo microsphere technology. Biol Psychiat 2003;53:204S–204S.
   PubMedGoogle Scholar
• Davis SS, Hardy JG, Newman SP, Wilding IR. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur J Nucl Med 1992,19:971–986.
   PubMedGoogle Scholar
• Cheng YH, Illum L, Davis SS. A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol. J Control Release 1998;55:203–212.
   PubMed Web of Science ®Google Scholar
• Orkoula MG, Kontoyannis CG. Non-destructive quantitative analysis of risperidone in film-coated tablets. J Pharm Biomed Anal 2008;47:631–635.
   PubMedGoogle Scholar
• Giovagnoli S, Blasi P, Ricci M, Rossi C. Biodegradable microspheres as carriers for native superoxide dismutase and catalase delivery. AAPS PharmSci Tech 2004;5:e51.
   PubMedGoogle Scholar
• Gref R, Quellec P, Sanchez A, Calvo P, Dellacherie E, Alonso MJ.Development and characterization of CyA-loaded poly(lactic acid)poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers. Eur J Pharm Biopharm 2001;51:111–118.
   PubMed Web of Science ®Google Scholar
• Khang G, Rhee JM, Jeong JK, Lee JS, Kim MS, Cho SH, Lee HB. Local drug delivery system using biodegradable polymers. Macromol Res 2003;11:207–223.
   Web of Science ®Google Scholar
• Gurpreet GS. Center for drug evaluation and research, chemistry review(s) of Risperdal Consta™. FDA [online] application numbers: 21–346. 2003;8–9. Available from the website: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21346_Risperdal%20Consta%20Long-Acting%20Injection_chemr.PDF
   Google Scholar
• Chu DF, Tian JW, Liu WH, Li Z, Li YX. Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: In vitro and in vivo studies and the application in the treatment of the impaired memory of mice. Chem Pharm Bull 2007;55:625–628.
   PubMedGoogle Scholar
• Su ZX, Sun FY, Shi YN, Jiang CJ, Meng QF, Teng LR, Li YX. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D, L-lactide-co-glycolide) microsphere. Chem Pharm Bull 2009;58(11).
   Google Scholar
• Al-Kassas R. Design and in vitro evaluation of gentamicin-Eudragit microspheres intended for intra-ocular administration. J Microencapsul 2004;21:71–81.
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang DR, Chen MH. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J Nanopart Res 2008;10:845–862.
   Web of Science ®Google Scholar
• Ramirez L, Pastoriza P, Herrero-Vanrell R.Biodegradable poly(DL-lactic-c o-glycolicacid) microspheres containing tetracaine hydrochloride. In vitro release profile. J Microencapsul 1999;16(1):105–115.
   PubMedGoogle Scholar
• Liu WH, Song JL, Liu K, Chu DF, Li YX. Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer’s disease. J Control Release 2005;107:417–427.
   PubMed Web of Science ®Google Scholar
• Berkland C, Kipper MJ, Narasimhan B, Kim K, Pack DW. Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres. J Control Release 2004;94:129–141.
   PubMed Web of Science ®Google Scholar
• Wang WJ, Zhou SB, Sun L, Huang C. Controlled delivery of Paracetamol and protein at different stages from core-shell biodegradable microspheres. Carbohyd Polym 2010;79:437–444.
   Web of Science ®Google Scholar
• Raman C, Berkland C, Kim K, Pack DW. Modeling small-molecule release from PLG microspheres: Effects of polymer degradation and nonuniform drug distribution. J Control Release 2005;103:149–158.
   PubMed Web of Science ®Google Scholar
• Bodmeier R, McGinity JW.Polylactic acid microspheres containing quinidine base and quinidine sulfate prepared by the solvent evaporation technique. I. Methods and morphology. J Microencapsul 1987;4:279–288.
   PubMed Web of Science ®Google Scholar
• Schwach G, Oudry N, Delhomme S, Luck M, Lindner H, Gurny R.Biodegradable microparticles for sustained release of a new GnRH antagonist. Part I: Screening commercial PLGA and formulation technologies. Eur J Pharm Biopharm 2003;56:327–336.
   PubMed Web of Science ®Google Scholar
• Zhu KJ, Jiang HL, Du XY, Wang J, Xu WX, Liu SF. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique. J Microencapsul 2001;18:247–260.
   PubMed Web of Science ®Google Scholar
• Fu X, Ping Q, Gao Y. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres. J Microencapsul 2005;22:705–714.
   PubMed Web of Science ®Google Scholar
• LeCorre P, Rytting JH, Gajan V, Chevanne F, LeVerge R. In vitro controlled release kinetics of local anaesthetics from poly(D, L-lactide) and poly(lactide-co-glycolide) microspheres. J Microencapsul 1997;14:243–255.
   PubMedGoogle Scholar
• Zolnik BS, Leary PE, Burgess DJ. Elevated temperature accelerated release testing of PLGA microspheres. J Control Release 2006;112:293–300.
   PubMed Web of Science ®Google Scholar
• Makino K, Mogi T, Ohtake N, Yoshida M, Ando S, Nakajima T, Ohshima H. Pulsatile drug release from poly (lactide-co-glycolide) microspheres: How does the composition of the polymer matrices affect the time interval between the initial burst and the pulsatile release of drugs? Colloids Surf B-Biointerf 2000;19:173–179.
   Web of Science ®Google Scholar
• Mundargi RC, Shelke NB, Rokhade AP, Patil SA, Aminabhavi TM. Formulation and in-vitro evaluation of novel starch-based tableted microspheres for controlled release of ampicillin. Carbohyd Polym 2008;71:42–53.
   Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1–20.
   PubMed Web of Science ®Google Scholar
• Freytag T, Dashevsky A, Tillman L, Hardee GE, Bodmeier R. Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres. J Control Release 2000;69:197–207.
   PubMed Web of Science ®Google Scholar
• Kim H, Fassihi R.Application of a binary polymer system in drug release rate modulation. 1. Characterization of release mechanism. J Pharm Sci 1997;86:316–322.
   PubMed Web of Science ®Google Scholar